Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Rising incidence of thyroid cancer in Serbia.

Slijepcevic N, Zivaljevic V, Paunovic I, Diklic A, Zivkovic P, Miljus D, Grgurevic A, Sipetic S.

Hippokratia. 2016 Jan-Mar;20(1):9-23.

2.
3.

The changing face of thyroid cancer in a population-based cohort.

Pathak KA, Leslie WD, Klonisch TC, Nason RW.

Cancer Med. 2013 Aug;2(4):537-44. doi: 10.1002/cam4.103.

4.

Clinicopathological implications of leptin and leptin receptor expression in papillary thyroid cancer.

Zhang GA, Hou S, Han S, Zhou J, Wang X, Cui W.

Oncol Lett. 2013 Mar;5(3):797-800.

5.

BMI, diet and female reproductive factors as risks for thyroid cancer: a systematic review.

Peterson E, De P, Nuttall R.

PLoS One. 2012;7(1):e29177. doi: 10.1371/journal.pone.0029177. Review.

6.

Thyroid cancer incidence among active duty U.S. military personnel, 1990-2004.

Enewold LR, Zhou J, Devesa SS, Berrington de Gonzalez A, Anderson WF, Zahm SH, Stojadinovic A, Peoples GE, Marrogi AJ, Potter JF, McGlynn KA, Zhu K.

Cancer Epidemiol Biomarkers Prev. 2011 Nov;20(11):2369-76. doi: 10.1158/1055-9965.EPI-11-0596.

7.
8.

Contralateral papillary thyroid cancer: does size matter?

Pitt SC, Sippel RS, Chen H.

Am J Surg. 2009 Mar;197(3):342-7. doi: 10.1016/j.amjsurg.2008.09.011.

9.

Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005.

Enewold L, Zhu K, Ron E, Marrogi AJ, Stojadinovic A, Peoples GE, Devesa SS.

Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):784-91. doi: 10.1158/1055-9965.EPI-08-0960.

Supplemental Content

Support Center